Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPM1K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DANCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
B4GALT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH9A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC42SE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADGRA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBQLN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCIAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISG20L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR89A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM161B-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on